Liquid biopsy‐based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results
Real-world experience using comprehensive liquid biopsy assays in patients with a wide range of haematologic malignancies, including solid tumours such as classic Hodgkin lymphoma, myeloma, and diffu…